Annual Report 2026Delivering Next-Generation Cardiopulmonary Imaging to the WorldOur visionWe envision a world where individuals with lung disease receive earlier diagnoses, more effective treatments, and compassionate care – leading to better outcomes and renewed hope.Key Highlights02Chair...
FY26 Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from 4DMedical
- Initial Director's Interest Notice - CJ
- Board transition and key personnel appointments
- Ceasing to be a substantial holder
- Application for quotation of securities - 4DX
- Cleansing Notice
Later from 4DMedical
- Appendix 4G and Corporate Governance Statement
- Notice of Annual General Meeting/Proxy Form
- Becoming a substantial holder
- Notification of cessation of securities - 4DX
- Addendum to 2026 Notice of Annual General Meeting
